Matching trials
834 results
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: Complete Statistical AnalysisIndependent statistical analysis of Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RESCUEIndependent statistical analysis of Renal Safety Evaluation After Dotarem®-Enhanced MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00650845).
- REST-ITIndependent statistical analysis of Reducing Suicidal Ideation Through Insomnia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689909).
- RESTOREIndependent statistical analysis of A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROPIndependent statistical analysis of Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00634972).
- SAGB-PMIndependent statistical analysis of Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543140).
- Salt to GrowIndependent statistical analysis of Physiologic Approach to Sodium Supplementation in Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03889197).
- SARCAIndependent statistical analysis of Lansoprazole to Treat Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442013).
- SCALPIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp: primary endpoint results, effect…
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SNIFFLE-3Independent statistical analysis of Efficacy & Safety of Nasal Influenza Immunisation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02549365).
- SPARCLIndependent statistical analysis of the SPARCL trial evaluating atorvastatin for prevention of stroke in patients with a previous stroke. Includes trial design, endpoints, statistical methodology, and interpretation.
- SPARTANIndependent statistical analysis of Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPETIndependent statistical analysis of Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPIRITIndependent statistical analysis of Antiarrhythmic Effects of Spironolactone in Patients With ICDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495712).
- STAR*DA detailed statistical analysis and educational interpretation of STAR*D, a phase 4 clinical study evaluating the relationship between depression symptoms and brain physiologic measures during antidepressant treatment.
- STARDUSTIndependent statistical analysis of Liraglutide and Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04881110).
- STOPDAPT-2A statistical analysis of STOPDAPT-2, a randomized phase 4 trial comparing 1-month versus 12-month dual antiplatelet therapy in coronary artery disease, including its design, composite endpoint, planned analysis, and statistical interpretation.
- SWEDESIndependent statistical analysis of Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SWITCH PROIndependent statistical analysis of A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study:…
- T-jet®Independent statistical analysis of Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TALOS-AMIA statistical analysis of TALOS-AMI, a randomized phase 4 trial comparing aspirin plus ticagrelor versus aspirin plus clopidogrel in stabilized patients with acute myocardial infarction. Includes trial design, endpoints, planned statistical methods,…
- TAPPASIndependent statistical analysis of Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TNTIndependent statistical analysis of the TNT trial (NCT00327691), a randomized phase 4 study evaluating atorvastatin for cardiovascular risk reduction through intensive LDL lowering.
- TRACEIndependent statistical analysis of Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TRANSFORMIndependent statistical analysis of Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TRANSITIndependent statistical analysis of A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate: primary endpoint results, effect estimate with confidence interval,…
- TSMIndependent statistical analysis of Drug and Non-Drug Treatment Of Severe Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00910689).
- VA CARDSIndependent statistical analysis of Coronary Artery Revascularization in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00326196).
- VOR-IISRIndependent statistical analysis of Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02969876).
- WAVEIndependent statistical analysis of Durvalumab Long-Term Safety and Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04078152).
- WISDOMAn independent statistical analysis of the WISDOM trial evaluating withdrawal versus continuation of amiodarone in successfully treated patients with persistent atrial fibrillation.
- WOESTIndependent statistical analysis of WOEST (NCT00769938), a randomized phase 4 trial evaluating antiplatelet and anticoagulant therapy strategies in patients undergoing coronary stenting with oral anticoagulation.
- YELLOW IIIIndependent statistical analysis of Effect of Evolocumab on Coronary Plaque Characteristics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04710368).